Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
Cervical cancer is the third most frequent neoplasm in Brazilian women (estimated risk of
 15.33 cases / 100,000 women by 2014), behind breast and colorectal cancer.

 This high incidence is explained by the pre-neoplastic lesions of the cervix being probably
 related to the practice of unsafe sex and to a poor local immune response against HPV.

 Human papillomavirus (HPV) infection affects people of any age, although it is more common in
 young people, probably due to increased sexual activity in that period.

 The association between high-risk HPV and anus neoplasm in men and women with
 immunodeficiency or immunosuppression has been confirmed and measures related to surveillance
 are standardized.

 In patients without immunodeficiencies, this association is still unclear, which may
 contribute to the lack of adequate standards to diagnose HPV and prevent cancer of the anus.

 The frequency of the cancer of anus previously considered low, is currently in considerable
 elevation, mainly squamous cell carcinoma (SCC).

 The causal relationship between this virus and cancer of the cervix and the anus is
 established. These facts have motivated the inclusion of this disease as STD, which justifies
 the necessity of adopting surveillance measures in the clinics of sexual, gynecological and
 urological diseases.

 Cancer of the anus, when diagnosed in the early stage, makes healing possible with less
 aggressive treatments, but in the advanced stage, abdominoperineal amputation is necessary.

 Concerned about possible anal cancer, some gynecologists have referred patients with genital
 HPV to search for anal infection.
Inclusion Criteria:

 Female patients aged 18-65 years with an anatomic pathology compatible with CIN II / CIN
 III, without restriction regarding skin color, race, ethnicity, religion; Patients of the
 Oncology Gynecology Service of the HCSL, registered in the hospital management system, in
 outpatient consultations; Those who agree to participate in the study and sign the ICF.
 Patients attended at the general gynecological surgery outpatient clinic (control group)
 with no evidence of colpocitological alteration.

 -

 Exclusion Criteria:

 Patients who withdraw the consent term. History of previous anal cancer / anal
 intraepithelial neoplasia. Immunosuppressed: HIV, SLE, users of immunosuppressive and
 transplanted drugs.

 -